Your browser doesn't support javascript.
loading
NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.
Chen, Xiaona; Hao, Yi; Liu, Yong; Zhong, Sheng; You, Yuehua; Ao, Keyi; Chong, Tuotuo; Luo, Xiaomin; Yin, Minuo; Ye, Ming; He, Hui; Lu, Anwei; Chen, Jianjun; Li, Xin; Zhang, Jian; Guo, Xia.
Afiliação
  • Chen X; Shenzhen Key Laboratory of Viral Oncology; Ministry of Science and Innovation, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Hao Y; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • Liu Y; Department of Ultrasound, South China Hospital of Shenzhen University, Shenzhen, Guangdong, China.
  • Zhong S; Department of Critical Care Medicine, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • You Y; Shenzhen Key Laboratory of Viral Oncology; Ministry of Science and Innovation, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Ao K; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • Chong T; Department of Stomatology, Longhua People's Hospital Affiliated with Southern Medical University, Shenzhen, Guangdong, China.
  • Luo X; School of Stomatology, Southern Medical University, Guangzhou, Guangdong, China.
  • Yin M; Shenzhen Key Laboratory of Viral Oncology; Ministry of Science and Innovation, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Ye M; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • He H; Shenzhen Key Laboratory of Viral Oncology; Ministry of Science and Innovation, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Lu A; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • Chen J; Shenzhen Key Laboratory of Viral Oncology; Ministry of Science and Innovation, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
  • Li X; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • Zhang J; Department of Obstetrics and Gynecology, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China.
  • Guo X; Department of Pathology, Affiliated Tumour Hospital of Xinjiang Medical University, Urumqi, Xinjiang, China.
Adv Sci (Weinh) ; 10(32): e2302705, 2023 11.
Article em En | MEDLINE | ID: mdl-37818745
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Adv Sci (Weinh) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China